SCIPIO BIOSCIENCE

This project will develop and perform the industrial scale-up of a game-changing scRNA-seq tool named DEEP-IN-CELL. This solution, in a kit format plus a cloud software analysis suite, will use the proprietary hydrogel-based RevGel technology of Asteria kit as a basis for a new generation of kit that ambitions to dramatically simplify access to single-cell studies with a shorter time to result, far easier, robust and authentic transcriptome-preserving technology multiplied by reducing cost per sample. This new generation of kit shall bring a similar revolution to the single-cell market as did the Qiagen RNA extraction kit in its time to the genomic market, while providing performances at par with that of the market gold standard and monopolistic costive instrument-based single-cell technology 10xGenomics. This next generation of single-cell RNAseq kit is expected to first launch in late 2024 with first applications to the international single-cell research market and to generate sales exceeding €50M by 2029. It is foreseen to become the quintessencial single-cell RNAseq kit that will open access to single-cell studies to a much broader research community.